Key Events This Week
27 Jul: New 52-week and all-time high at Rs.600.50, intraday peak Rs.612
28 Jul: Minor correction with a 0.63% decline amid lower volumes
29 Jul: Stable trading with negligible change despite Sensex rally
30 Jul: Price rebounds 1.80% supported by positive market sentiment
31 Jul: Week closes at Rs.579.15, down 1.87% on low volume

Thyrocare Technologies Ltd Surges 7.14% to Day's High of Rs 612 — Outperforms Sector by 7.24 Percentage Points
2026-07-27 11:17:33The Sensex advanced 0.76% on 27 Jul 2026, yet Thyrocare Technologies Ltd outpaced the broader market with a robust 7.14% gain, touching an intraday high of Rs 612. This 7.24 percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.
Read full news article
Broad-Based Technical Strength Lifts Thyrocare Technologies Ltd to 52-Week High of Rs 600.5
2026-07-27 09:54:11With a decisive surge to Rs 600.5 on 27 Jul 2026, Thyrocare Technologies Ltd has marked a new 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum that outpaces its sector and the broader market.
Read full news articleThyrocare Technologies Ltd Gains 8.60%: 6 Key Factors Driving the Surge
2026-07-25 14:00:07
Key Events This Week
20 Jul: Intraday high surge of 7.18% to Rs.558.95
23 Jul: Q1 FY27 results reveal 34% profit growth
24 Jul: New 52-week and all-time high at Rs.597.5
24 Jul: Heavy trading volume and institutional interest
24 Jul: Week closes at Rs.564.95 (+8.60%)
Are Thyrocare Technologies Ltd latest results good or bad?
2026-07-24 19:17:24Thyrocare Technologies Ltd has reported its financial results for the quarter ended June 2026, showcasing notable operational performance. The company achieved net sales of ₹240.02 crores, reflecting a year-on-year growth of 24.34% compared to ₹193.03 crores in the same quarter last year. This revenue growth is indicative of the company's successful expansion of its diagnostic testing portfolio, which now includes over 920 distinct tests. Net profit for the quarter stood at ₹52.19 crores, marking a year-on-year increase of 34.06% from ₹38.93 crores in the previous year. This growth in net profit is supported by an operating profit before depreciation, interest, and tax of ₹77.27 crores, which translates to a healthy operating margin of 32.19%. This margin, while slightly lower than the previous quarter, still reflects the company's strong cost management and operational efficiency. The return on equity (R...
Read full news articleThyrocare Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates
09-Dec-2019 | Source : NSEThyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates.
Thyrocare Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates
03-Dec-2019 | Source : NSEThyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Thyrocare Technologies Limited - Other General Purpose
21-Nov-2019 | Source : NSEThyrocare Technologies Limited has informed the Exchange that Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended the Company has submitted to the Exchange a copy of Disclosure of Related Party Transactions during the half year ended on September 30, 2019 on a consolidated basis.
Corporate Actions
No Upcoming Board Meetings
Thyrocare Technologies Ltd has declared 70% dividend, ex-date: 23 Jun 26
No Splits history available
Thyrocare Technologies Ltd has announced 2:1 bonus issue, ex-date: 28 Nov 25
No Rights history available










